2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective
Charles P. Hannon, Susan M. Goodman, Matthew S. Austin, Adolph Yates, Gordon Guyatt, Vinay K. Aggarwal, Joshua F. Baker, Phyllis Bass, Delamo Isaac Bekele, Danielle Dass, Hassan M.K. Ghomrawi, David S. Jevsevar, C. Kent Kwoh, Claudette M. Lajam, Charis F. Meng, Larry W. Moreland, Linda I. Suleiman, Jesse Wolfstadt, Kimberly Bartosiak, Nicholas A. BedardJason L. Blevins, Anna Cohen-Rosenblum, P. Maxwell Courtney, Ruth Fernandez-Ruiz, Elizabeth B. Gausden, Nilasha Ghosh, Lauren K. King, Alexa Simon Meara, Bella Mehta, Reza Mirza, Adam J. Rana, Nancy Sullivan, Marat Turgunbaev, Katherine D. Wysham, Kevin Yip, Linda Yue, Michael G. Zywiel, Linda Russell, Amy S. Turner, Jasvinder A. Singh
Dive into the research topics of '2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective'. Together they form a unique fingerprint.